Showing results (2201-2210 of 2,418) with videos related to

Sort By:
Pageof 242
Acta Haematologica|January 5, 2023
On Behalf of the SFGM-TC: Prophylactic Donor Lymphocyte Infusion in Patients Treated with Allogeneic Stem-Cell Transplantation for High-Risk Myelodysplastic Syndrome and Acute Myeloid LeukemiaCharles Guisnel, Luciane Schirmer, Stéphane Morisset, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1996
A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapyB Audhuy, P Cappelaere, M Martin, et al.
Gut Microbes|September 7, 2020
Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengtheningThomas Hueso, Kenneth Ekpe, Camille Mayeur, et al.
Cardiovascular and Interventional Radiology|November 19, 2021
Evaluating the Effectiveness of Yttrium-90 Glass Microspheres in the Treatment of Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, and Metastatic Colorectal Cancer in Practice: Protocol for the Prospective PROACTIF Phase IV Registry Study in FranceEtienne Garin, Jean-Baptiste Pinaquy, Clement Bailly, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 8, 2022
[Artificial urinary sphincter in patients with urinary incontinence after High Intensity Focused ultrasound]D Robin, B Peyronnet, I Bentellis, et al.
Diagnostics (Basel, Switzerland)|July 29, 2023
Patient-Reported Outcomes of Endovascular Treatment of Post-Thrombotic Syndrome: Ancillary Study of a French CohortKévin Guillen, Frédéric Thony, Costantino Del Giudice, et al.
Leukemia|January 30, 2020
Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantationRathana Kim, Nicolas Boissel, Aurore Touzart, et al.
Blood Advances|February 11, 2021
Real-life experience with CPX-351 and impact on the outcome of high-risk AML patients: a multicentric French cohortEdmond Chiche, Ramy Rahmé, Sarah Bertoli, et al.
Haematologica|June 25, 2026
Prognostic impact of t(9;11) and del(7q) as intermediate-risk abnormalities in acute myeloid leukemia following allo-transplant: an Acute Leukemia Working Party study from the European Society for Blood and Marrow TransplantationIman Abou Dalle, Jacques-Emmanuel Galimard, Ali Bazarbachi, et al.
Blood|April 18, 2014
Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemiaKheira Beldjord, Sylvie Chevret, Vahid Asnafi, et al.
Pageof 242